Reshoring Pharmaceutical Production: Are Buy America Laws Enough?
By Kenneth Rapoza, Industry Analyst, CPA President Trump and many members of Congress are talking about reshoring pharmaceutical production. We look at the benefits of
By Kenneth Rapoza, Industry Analyst, CPA President Trump and many members of Congress are talking about reshoring pharmaceutical production. We look at the benefits of
By Ken Rapoza, CPA Industry Analyst Major pharmaceutical importers have pushed back against the White House’s proposal to support domestic labs. But on Thursday, American
Editor’s note: Rosemary Gibson is a CPA member. Rosemary Gibson is a senior advisor at the Hastings Center, a bioethics research institute, and is the
Editor’s note: The Biden campaign released a plan to rebuild domestic manufacturing. There is recognition that we need to focus upon critical supply chains. However,
Editor’s note: Chinese companies’ fraud is not just in the stock market, it is in the FDA approval database. WSJ analysis shows gaps in FDA
Editor’s note: FDA is complicit in offshoring our drug supply chain. We need to bring it back to the US. The Food and Drug Administration
Editor’s Note: Michael Stumo is CEO of the Coalition for a Prosperous America. Follow him at @michael_stumo The coronavirus pandemic has revealed a troubling truth: Global
Editor’s note: We’ve been pushing for this for a while. Let’s hope Friday is indeed the day. The White House is preparing an executive order
By David Morse, Tax Policy Director The president just signed the CARES Act after a week of negotiations in the Senate, and a Congressional kerfuffle
Excerpt: America’s small businesses, our machinists, die-casters, plastic injection molders, electronics parts suppliers, and others are eager to get to work providing the medical equipment the